Reference sources: Sigma-Aldrich 5-Amino-1MQ (SML2832) | NIH PMC NNMT Inhibitor Research Regulatory Notice 5-Amino-1MQ is an unapproved new drug compound
Potential concerns can include: Injection site irritation, bruising, or infection risk if sterile technique is poor Unwanted systemic effects, like feeling off, headaches, or fatigue in some individuals Interactions with existing conditions or medications Masking pain so someone returns to activity too quickly, re injuring the area And then there is the bigger safety issue that does not get enough attention
With over millions of red blood cells being produced daily, it is imperative that we consume an adequate amount of vitamin B12 in our diet or through supplementation
How should this product be stored
But the jump from C57BL/6 mice to humans involves differences in metabolic rate, NNMT tissue distribution, adipose tissue physiology, and drug metabolism that preclinical data cannot address
Great beginning week It has only been a month but Im very happy so far